Clinical outcomes of immunotherapy in metastatic pancreatic carcinoma: A systematic review and meta-analysis. Overall survival (OS) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback